← Back to Search

Cognitive Behavioral Therapy for Anxiety

N/A

Waitlist Available

Led By Patricia Furer, PhD

Research Sponsored by University of Manitoba

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 weeks, 12 weeks, 24 weeks

Awards & highlights

Study Summary

This trial will recruit people with Inflammatory Bowel Disease who are interested in a web-based program to help manage stress, anxiety, and depression.

Eligible Conditions

Anxiety
Inflammatory Bowel Disease
Depression

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 weeks, 12 weeks, 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 weeks, 12 weeks, 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 12 weeks, 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Hospital Anxiety and Depression Scale (HADS)

Change in Perceived Stress Scale 4 (PSS-4)

Secondary outcome measures

Change in Clinical Global Impression - Improvement scale (CGI-I)

Change in Inflammatory Bowel Disease Symptom Inventory - Short Form (IBDSI)

Change in Patient-Reported Outcomes Measurement Information System - 29 (PROMIS-29)

+1 more

Side effects data

From 2021 Phase 4 trial • 12 Patients • NCT04135937

irritability

100%

80%

60%

40%

20%

Study treatment Arm

MESH

Trial Design

1Treatment groups

Experimental Treatment

Group I: Cognitive Behavioral TherapyExperimental Treatment1 Intervention

Online cognitive behavioral therapy intervention for 2 hours a week for 12 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive Behavioral Therapy

2016

Completed Phase 4

~3120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor

595 Previous Clinical Trials

199,472 Total Patients Enrolled

8 Trials studying Anxiety

554 Patients Enrolled for Anxiety

Patricia Furer, PhDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor currently enrolling participants?

"Clinicaltrials.gov displays that this study, which commenced on April 18th 2019 and was most recently revised September 27 2021, is no longer seeking participants. However, at present there are 1,535 other trials welcoming volunteers."

Answered by AI

What purpose does this research endeavor hope to accomplish?

"This trial intends to measure the Change in Hospital Anxiety and Depression Scale (HADS) over a duration of Baseline, 6 weeks, 12 weeks, 24 weeks. Secondary outcomes include changes in Patient-Reported Outcomes Measurement Information System - 29 (PROMIS-29), Work and Social Adjustment Scale (WSAS), and Clinical Global Impression - Improvement scale (CGI-I). PROMIS-29 is an index measuring health related quality of life with higher scores indicating poorer symptomology or better functioning depending on its domain. WSAS gauges how inflammatory bowel disease impacts daily activities with greater levels correlating to higher"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Managing Stress With Inflammatory Bowel Disease

2019. "Managing Stress With Inflammatory Bowel Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03852745.

All > Inflammatory Bowel Disease